CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER
- 1 February 1983
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 321 (8319) , 257-261
- https://doi.org/10.1016/s0140-6736(83)91683-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of Primary Breast Cancer with Chemotherapy and TamoxifenNew England Journal of Medicine, 1981
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug toleranceCancer, 1977
- L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Specific Estrogen Binding by the Cytoplasm of Human Breast CarcinomaJournal of Clinical Endocrinology & Metabolism, 1970
- Prophylactic oophorectomy in breast cancer therapy: A preliminary reportThe American Journal of Surgery, 1969
- The role of prophylactic castration in the therapy of human mammary cancerEuropean Journal of Cancer (1965), 1967
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958